BMAL1 and acute lymphoblastic leukemia: The interference on the biological clock obtained by challenge with a chemical agonist of the REV-ERBα nuclear receptor confirmed the crucial role played by BMAL1 in favoring cell proliferation in T-ALL and the effective pharmacological effect of this chemical compound, as evaluated by measurement of the half maximal inhibitory concentration (IC50).